Last reviewed · How we verify

NCT07063420: TREAT2D

Patient Centered Multi-Agent Decision Support System (PCM-DSS) for Healthcare Providers

Recruiting now NA Last updated 13 November 2025
What this trial tests

NA trial testing Continuous Glucose Monitor (CGM) + Patient Centered Multi-Agent Decision Support System (PCM-DSS) in Type 2 Diabetes Treated With Insulin in 18 participants. Currently enrolling.

Timeline
28 October 2025
Primary endpoint
31 July 2026
31 July 2026

Quick facts

Lead sponsorDaniel Chernavvsky, MD
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment18
Start date28 October 2025
Primary completion31 July 2026
Estimated completion31 July 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Daniel Chernavvsky, MD

Who can join

18 and older, any sex, with Type 2 Diabetes Treated With Insulin. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Decision Support System (Software) for multi antidiabetic drug therapy use in type 2 diabetes (T2D).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Type 2 Diabetes Treated With Insulin

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07063420.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing